{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:33:31Z","timestamp":1788820411108,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45007-0","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:25:05Z","timestamp":1774311905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The utility of aqueous and serum apolipoprotein E and galectin-3 as biomarkers of neuroinflammation in glaucoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Hani","family":"El Helwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henisk","family":"Falah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Meeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silas L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Sol\u00e1-Del","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica A.","family":"Margeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"8","key":"45007_CR1","doi-asserted-by":"publisher","first-page":"a017269","DOI":"10.1101\/cshperspect.a017269","volume":"4","author":"I Soto","year":"2014","unstructured":"Soto, I. & Howell, G. R. The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect. Med. 4 (8), a017269 (2014).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"45007_CR2","first-page":"143","volume":"11","author":"HL Zeng","year":"2018","unstructured":"Zeng, H. L. & Shi, J. M. The role of microglia in the progression of glaucomatous neurodegeneration- a review. Int. J. Ophthalmol. 11, 143\u2013149 (2018).","journal-title":"Int. J. Ophthalmol."},{"key":"45007_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jnr.24256","volume":"97","author":"X Wei","year":"2019","unstructured":"Wei, X., Cho, K. S., Thee, E. F., Jager, M. J. & Chen, D. F. Neuroinflammation and microglia in glaucoma: time for a paradigm shift. J. Neurosci. Res. 97, 70\u201376 (2019).","journal-title":"J. Neurosci. Res."},{"key":"45007_CR4","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.ymthe.2018.08.017","volume":"26","author":"A Bosco","year":"2018","unstructured":"Bosco, A. et al. Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma. Mol. Ther. 26, 2379\u20132396 (2018).","journal-title":"Mol. Ther."},{"key":"45007_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/IJG.0000000000000447","volume":"25","author":"G Chidlow","year":"2016","unstructured":"Chidlow, G., Ebneter, A., Wood, J. P. & Casson, R. J. Evidence supporting an association between expression of major histocompatibility complex II by microglia and optic nerve degeneration during experimental glaucoma. J. Glaucoma. 25, 681\u2013691 (2016).","journal-title":"J. Glaucoma"},{"key":"45007_CR6","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1167\/iovs.07-1337","volume":"49","author":"A Bosco","year":"2008","unstructured":"Bosco, A. et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA\/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 49, 1437\u20131446 (2008).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"45007_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.nbd.2016.05.002","volume":"93","author":"JL Cueva Vargas","year":"2016","unstructured":"Cueva Vargas, J. L., Belforte, N. & Di Polo, A. The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling. Neurobiol. Dis. 93, 156\u2013171 (2016).","journal-title":"Neurobiol. Dis."},{"key":"45007_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1167\/iovs.15-18024","volume":"57","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. The effect of A2A receptor antagonist on microglial activation in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 57, 776\u2013786 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"45007_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581e569 (2017).","journal-title":"Immunity"},{"key":"45007_CR10","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290e1217 (2017).","journal-title":"Cell"},{"key":"45007_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky, O. & Weiner, H. L. Microglial signatures and their role in health and disease. Nat. Rev. Neurosci. 19, 622\u2013635 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"45007_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger, J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat. Neurosci. 23, 194\u2013208 (2020).","journal-title":"Nat. Neurosci."},{"key":"45007_CR13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.immuni.2022.07.014","volume":"55","author":"MA Margeta","year":"2022","unstructured":"Margeta, M. A. et al. Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma. Immunity 55, 1627\u20131644e1627 (2022).","journal-title":"Immunity"},{"key":"45007_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.brainres.2014.08.053","volume":"1586","author":"K Omodaka","year":"2014","unstructured":"Omodaka, K. et al. Neuroprotective effect against axonal damage-induced retinal ganglion cell death in apolipoprotein E-deficient mice through the suppression of kainate receptor signaling. Brain Res. 1586, 203\u2013212 (2014).","journal-title":"Brain Res."},{"issue":"5123","key":"45007_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261 (5123), 921\u2013923 (1993).","journal-title":"Science"},{"issue":"8","key":"45007_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.61.8.3","volume":"61","author":"MA Margeta","year":"2020","unstructured":"Margeta, M. A. et al. Association of APOE with primary open-angle glaucoma suggests a protective effect for APOE epsilon4. Invest. Ophthalmol. Vis. Sci. 61 (8), 3 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"45007_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/01.ijg.0000212217.19804.a7","volume":"15","author":"CY Lam","year":"2006","unstructured":"Lam, C. Y. et al. Association of apolipoprotein E polymorphisms with normal tension glaucoma in a Chinese population. J. Glaucoma. 15, 218\u2013222 (2006).","journal-title":"J. Glaucoma"},{"key":"45007_CR18","first-page":"609","volume":"11","author":"F Mabuchi","year":"2005","unstructured":"Mabuchi, F. et al. The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population. Mol. Vis. 11, 609\u2013612 (2005).","journal-title":"Mol. Vis."},{"key":"45007_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.csbj.2017.05.003","volume":"15","author":"IF Tudorache","year":"2017","unstructured":"Tudorache, I. F., Trusca, V. G., Gafencu, A. V., Apolipoprotein, E. & - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features. Comput. Struct. Biotechnol. J. 15, 359\u2013365. https:\/\/doi.org\/10.1016\/j.csbj.2017.05.003 (2017).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"4","key":"45007_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/nan.12529","volume":"45","author":"M Tzioras","year":"2019","unstructured":"Tzioras, M., Davies, C., Newman, A., Jackson, R. & Spires-Jones, T. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer\u2019s disease. Neuropathol. Appl. Neurobiol. 45 (4), 327\u2013346. https:\/\/doi.org\/10.1111\/nan.12529 (2019).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"45007_CR21","doi-asserted-by":"publisher","unstructured":"Arnaud, L. et al. APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-\u03baB activation. Cell Rep. 40 (7), 111200 https:\/\/doi.org\/10.1016\/j.celrep.2022.111200 (2022).","DOI":"10.1016\/j.celrep.2022.111200"},{"issue":"1","key":"45007_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/cimb43010018","volume":"43","author":"J Iannucci","year":"2021","unstructured":"Iannucci, J., Sen, A. & Grammas, P. Isoform-specific effects of apolipoprotein E on markers of inflammation and toxicity in brain glia and neuronal cells in vitro. Curr. Issues Mol. Biol. 43 (1), 215\u2013225. https:\/\/doi.org\/10.3390\/cimb43010018 (2021).","journal-title":"Curr. Issues Mol. Biol."},{"issue":"3","key":"45007_CR23","doi-asserted-by":"publisher","first-page":"112196","DOI":"10.1016\/j.celrep.2023.112196","volume":"42","author":"S Lee","year":"2023","unstructured":"Lee, S. et al. APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell. Rep. 42 (3), 112196 (2023).","journal-title":"Cell. Rep."},{"key":"45007_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2147\/NDT.S84266","volume":"11","author":"VV Giau","year":"2015","unstructured":"Giau, V. V., Bagyinszky, E., An, S. S. & Kim, S. Y. Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis. Treat. 11, 1723\u20131737 (2015).","journal-title":"Neuropsychiatr Dis. Treat."},{"key":"45007_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","volume":"51","author":"AD Marais","year":"2019","unstructured":"Marais, A. D. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Pathology 51, 165\u2013176 (2019).","journal-title":"Pathology"},{"key":"45007_CR26","doi-asserted-by":"publisher","first-page":"104809","DOI":"10.1016\/j.nbd.2020.104809","volume":"138","author":"AB Martinez-Martinez","year":"2020","unstructured":"Martinez-Martinez, A. B. et al. Beyond the CNS: the many peripheral roles of APOE. Neurobiol. Dis. 138, 104809 (2020).","journal-title":"Neurobiol. Dis."},{"key":"45007_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","volume":"138","author":"A Boza-Serrano","year":"2019","unstructured":"Boza-Serrano, A. et al. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer\u2019s disease. Acta Neuropathol. 138, 251\u2013273 (2019).","journal-title":"Acta Neuropathol."},{"key":"45007_CR28","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","volume":"10","author":"JJ Siew","year":"2019","unstructured":"Siew, J. J. et al. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease. Nat. Commun. 10, 3473 (2019).","journal-title":"Nat. Commun."},{"key":"45007_CR29","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","volume":"182","author":"HR Jiang","year":"2009","unstructured":"Jiang, H. R. et al. Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J. Immunol. 182, 1167\u20131173 (2009).","journal-title":"J. Immunol."},{"key":"45007_CR30","first-page":"253","volume":"32","author":"CA Abreu","year":"2017","unstructured":"Abreu, C. A., De Lima, S. V., Mendonca, H. R., Goulart, C. O. & Martinez, A. M. Absence of galectin-3 promotes neuroprotection in retinal ganglion cells after optic nerve injury. Histol. Histopathol. 32, 253\u2013262 (2017).","journal-title":"Histol. Histopathol"},{"issue":"5","key":"45007_CR31","doi-asserted-by":"publisher","first-page":"2002559","DOI":"10.1183\/13993003.02559-2020","volume":"57","author":"N Hirani","year":"2021","unstructured":"Hirani, N. et al. Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis. Eur. Respir J. 57 (5), 2002559 (2021).","journal-title":"Eur. Respir J."},{"key":"45007_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","volume":"185","author":"AC Mackinnon","year":"2012","unstructured":"Mackinnon, A. C. et al. Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3. Am. J. Respir Crit. Care Med. 185, 537\u2013546 (2012).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"45007_CR33","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/cbic.201600285","volume":"17","author":"T Delaine","year":"2016","unstructured":"Delaine, T. et al. Galectin-3-binding glycomimetics that strongly reduce bleomycin-induced lung fibrosis and modulate intracellular glycan recognition. Chembiochem 17, 1759\u20131770 (2016).","journal-title":"Chembiochem"},{"issue":"1","key":"45007_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13041-024-01160-z","volume":"17","author":"A Rombaut","year":"2024","unstructured":"Rombaut, A., Brautaset, R., Williams, P. A. & Tribble, J. R. Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma. Mol. Brain. 17 (1), 84. https:\/\/doi.org\/10.1186\/s13041-024-01160-z (2024).","journal-title":"Mol. Brain"},{"issue":"11","key":"45007_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.11.11.1","volume":"11","author":"KM Pitts","year":"2022","unstructured":"Pitts, K. M. et al. Sol\u00e1-Del Valle DA. Neurodegeneration markers Galectin-3 and apolipoprotein E Are elevated in the aqueous humor of eyes with glaucoma. Transl Vis. Sci. Technol. 11 (11), 1 (2022).","journal-title":"Transl Vis. Sci. Technol."},{"key":"45007_CR36","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2147\/OPTH.S417664","volume":"17","author":"JB Lin","year":"2023","unstructured":"Lin, J. B. et al. Sol\u00e1-Del Valle D. Neurofilament light chain in aqueous humor as a marker of neurodegeneration in glaucoma. Clin. Ophthalmol. 17, 2209\u20132217 (2023).","journal-title":"Clin. Ophthalmol."},{"issue":"2","key":"45007_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/tvst.14.2.24","volume":"14","author":"JB Lin","year":"2025","unstructured":"Lin, J. B. et al. Evaluation of serum and aqueous humor neurofilament light chain as markers of neurodegeneration in glaucoma. Transl Vis. Sci. Technol. 14 (2), 24. https:\/\/doi.org\/10.1167\/tvst.14.2.24 (2025).","journal-title":"Transl Vis. Sci. Technol."},{"key":"45007_CR38","unstructured":"Champely, S. & Pwr Basic functions for power analysis.  https:\/\/CRAN.R-project.org\/package=pwr (2020)."},{"key":"45007_CR39","unstructured":"American Academy of Ophthalmic Executives. Glaucoma ICD-10-CM Quick Reference Guide (American Glaucoma Society and American Academy of Ophthalmology, 2020)."},{"issue":"8","key":"45007_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.61.8.3","volume":"61","author":"MA Margeta","year":"2020","unstructured":"Margeta, M. A. et al. Association of APOE with primary open-angle glaucoma suggests a protective effect for APOE \u03b54. Invest. Ophthalmol. Vis. Sci. 61 (8), 3. https:\/\/doi.org\/10.1167\/iovs.61.8.3 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"45007_CR41","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/bjo-2021-320828","volume":"107","author":"N Woltsche","year":"2023","unstructured":"Woltsche, N. et al. Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucoma. Br. J. Ophthalmol. 107 (10), 1432\u20131437. https:\/\/doi.org\/10.1136\/bjo-2021-320828 (2023).","journal-title":"Br. J. Ophthalmol."},{"issue":"11","key":"45007_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.12.11.9","volume":"12","author":"S Wilson","year":"2023","unstructured":"Wilson, S. et al. Correlation of aqueous, vitreous, and serum protein levels in patients with retinal diseases. Transl Vis. Sci. Technol. 12 (11), 9 (2023).","journal-title":"Transl Vis. Sci. Technol."},{"issue":"3","key":"45007_CR43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/infdis\/jiz118","volume":"220","author":"C Godfrey","year":"2019","unstructured":"Godfrey, C. et al. Obesity and fat metabolism in human immunodeficiency virus-infected individuals: Immunopathogenic mechanisms and clinical implications. J. Infect. Dis. 220 (3), 420\u2013431. https:\/\/doi.org\/10.1093\/infdis\/jiz118 (2019).","journal-title":"J. Infect. Dis."},{"issue":"9","key":"45007_CR44","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ophtha.2022.04.023","volume":"129","author":"KM Madjedi","year":"2022","unstructured":"Madjedi, K. M. et al. The association between serum lipids and intraocular pressure in 2 large United Kingdom cohorts. Ophthalmology 129 (9), 986\u2013996 (2022).","journal-title":"Ophthalmology"},{"key":"45007_CR45","doi-asserted-by":"publisher","first-page":"618970","DOI":"10.3389\/fmed.2021.618970","volume":"8","author":"M Shao","year":"2021","unstructured":"Shao, M., Li, Y., Teng, J., Li, S. & Cao, W. Association between serum lipid levels and patients with primary angle-closure glaucoma in China: A cross sectional, case-control study. Front. Med. (Lausanne). 8, 618970. https:\/\/doi.org\/10.3389\/fmed.2021.618970 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"45007_CR46","doi-asserted-by":"publisher","unstructured":"Wang, S., Bao, X. & Hyperlipidemia blood lipid level, and the risk of glaucoma: A meta-analysis. Invest. ophthalmol. Vis. Sci. 60 (4), 1028\u20131043. https:\/\/doi.org\/10.1167\/iovs.18-25845 (2019).","DOI":"10.1167\/iovs.18-25845"},{"issue":"1","key":"45007_CR47","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1038\/s41467-023-38466-w","volume":"14","author":"OA Zeleznik","year":"2023","unstructured":"Zeleznik, O. A. et al. Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank. Nat. Commun. 14 (1), 2860. https:\/\/doi.org\/10.1038\/s41467-023-38466-w (2023).","journal-title":"Nat. Commun."},{"issue":"1","key":"45007_CR48","doi-asserted-by":"publisher","first-page":"31957","DOI":"10.1038\/s41598-024-83499-w","volume":"14","author":"F Sumer","year":"2024","unstructured":"Sumer, F., Subasi, S., Bahceci, I. & Satilmaz, F. Evaluation of serum galectin-3 concentration as a potential biomarker in exudative-type age-related macular degeneration. Sci. Rep. 14 (1), 31957. https:\/\/doi.org\/10.1038\/s41598-024-83499-w (2024).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45007-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:01:55Z","timestamp":1778760115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45007-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45007"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45007-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14787"}}